Table 2

Summary table of baseline demographic and clinical data

Fast-trackWaiting list
PatientsN=26N=27
Age (years)67.1 (10.9)70.6 (10.3)
Male20 (77%)18 (67%)
Ethnicity
 White UK21 (81%)20 (74%)
 Black or Black British1 (4%)2 (8%)
 Asian or Asian British4 (15%)5 (18%)
Disease
 IPF22 (85%)22 (82%)
 NSIP4 (15%)5 (18%)
Diagnostic biopsy
 Surgical8 (31%)6 (22%)
 Not carried out18 (69%)21 (78%)
% predicted TLCO
 Mean (SD)25 (10.7)23 (5.8)
 Not carried out4 (15%)4 (15%)
Extent of disease on CT
 Limited (<40%)3 (12%)3 (11%)
 Indeterminate (40–60%)9 (35%)14 (52%)
 Extensive (>60%)14 (54%)10 (37%)
Extent of honeycombing on CT
 Limited (<15%)10 (38%)11 (41%)
 Indeterminate (15–35%)11 (42%)10 (37%)
 Extensive (>35%)5 (19%)6 (22%)
Composite Physiological Index
 >5019 (73%)27 (100%)
 Mean (SD)66.5 (4.0)64.8 (3.6)
 Not carried out7 (27%)*0
Using oxygen
 Yes20 (77%)23 (85%)
 Litres/h used3 (1.4)3 (1.1)
 Usage in 24 h19 (6.6)21 (5.3)
Comorbidities
 Yes17 (65%)13 (48%)
 Heart failure10
 COPD41
 Pulmonary embolism10
 TB00
 Cancer11
 Diabetes54
 Other1310
CarersN=19N=26
Age61.3 (14.0)60.3 (13.1)
Male6 (32%)6 (23%)
Ethnicity
 White UK17 (90%)18 (69%)
 Black or Black British1 (5%)2 (8%)
 Asian or Asian British1 (5%)6 (23%)
  • Data are means (SD) or numbers (%).

  • *Three patients were recruited who had end-stage disease clinically, did not have extensive disease or honeycombing on CT and were too unwell to complete lung function tests.

  • IPF, idiopathic pulmonary fibrosis; NSIP, Non-specific interstitial pneumonia; TLCO, carbon monoxide transfer factor.